OTC Markets OTCPK - Delayed Quote USD
Ascentage Pharma Group International (ASPHF)
5.82
0.00
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-712,004
-726,077
-653,915
-604,679
-609,956
Investing Cash Flow
-44,582
21,922
-384,612
-466,522
-107,367
Financing Cash Flow
310,023
368,751
619,268
1,781,387
1,040,003
End Cash Position
943,428
1,038,048
1,345,639
1,706,886
1,019,979
Capital Expenditure
-38,588
-56,844
-236,963
-436,629
-251,476
Issuance of Capital Stock
533,945
470,089
19
1,300,645
634,217
Issuance of Debt
209,417
953,500
763,617
599,737
527,805
Repayment of Debt
-339,884
-956,091
-54,504
-51,150
-95,000
Repurchase of Capital Stock
-7,882
-5,923
-26,776
-25,874
--
Free Cash Flow
-750,592
-782,921
-890,878
-1,041,308
-861,432
12/31/2020 - 5/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BEAM.MX Beam Therapeutics Inc.
390.00
+4.18%
T3X.F Telix Pharmaceuticals Limited
16.89
+6.93%
MBX MBX Biosciences, Inc.
9.27
+3.11%
BCAX Bicara Therapeutics Inc.
15.63
+0.77%
TVTX Travere Therapeutics, Inc.
17.63
+5.57%
ASND Ascendis Pharma A/S
160.45
+1.46%
TECH Bio-Techne Corporation
50.78
+1.24%
MGNX MacroGenics, Inc.
1.7900
+4.68%
ONC BeiGene, Ltd.
256.16
+2.82%
RPRX Royalty Pharma plc
32.03
+1.07%